Anzeige
Erschienen in:
28.05.2022 | Reviews and Scientific Meetings and New Research Implications (S. Virani, Section Editor)
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions
Erschienen in: Current Atherosclerosis Reports | Ausgabe 8/2022
Einloggen, um Zugang zu erhaltenAbstract
Purpose of Review
Focused review highlighting select studies presented at the 2022 American College of Cardiology (ACC) Scientific Sessions.
Recent Findings
Included studies assessed the impact of a low-sodium diet on heart failure outcomes (SODIUM-HF); outcomes of pregnant patients with chronic hypertension treated with antihypertensive therapies (CHAP); cardiovascular outcomes in patients with type 2 diabetes and renal impairment treated with sotagliflozin (SCORED); a safety and efficacy study investigating SLN360, a short interfering RNA targeting lipoprotein(a) (APOLLO); a supermarket and web-based intervention targeting nutrition for cardiovascular risk reduction (SuperWIN); a superiority trial comparing myocardial injury following very mild perioperative hypothermia versus aggressive warming after non-cardiac surgery (PROTECT); and 3-year efficacy outcomes of renal denervation on blood pressure reduction from the SPYRAL HTN-ON MED pilot study.
Summary
Research presented at the 2022 ACC Scientific Sessions underscores the new potential and meaningful impact of cardiovascular disease prevention and management interventions.